Management of oral mucositis using low-level laser therapy in nasopharyngeal cancer patients receiving chemo-radiotherapy: a randomized-controlled trial (MAGNETO)

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000041531

Enrollment

Unknown

Registered

2020-12-27

Start date

2020-12-23

Completion date

Unknown

Last updated

2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal cancer

Interventions

1:LLLT

2:Sham

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Adult Chinese patients with primary nasopharyngeal cancer (NPC) who will be receiving chemo-radiotherapy will be recruited at the out-patient clinic in the department of clinical oncology, Queen Mary Hospital.

Exclusion criteria

Exclusion criteria: Patients with a history of cancer or previous surgery for NPC, with trismus, any clinically compromised condition that impairs wound healing (e.g. diabetes), any distant metastasis, prior irradiation or chemotherapy for other H&N malignancies, previous adverse reactions to laser treatment, known radiation hypersensitivity, age 75y or inability to give informed consent will be excluded.

Design outcomes

Primary

Measure	Time frame
RTOG mucositis oral;	—

Countries

China

Contacts

Public ContactDr LEE Wee Yee Shara

The HK Polytechnic University

drsharalee@gmail.com+852 93436000

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026